Global Intravenous (IV) Equipment Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

 Intravenous (IV) Equipment Market Size

• The global intravenous (IV) equipment market size was valued at USD 15.86 billion in 2024 and is expected to reach USD 26.64 billion by 2032, at a CAGR of 6.70% during the forecast period
•  This growth is primarily driven by factors such as the rising geriatric population, increased incidence of chronic diseases, expanding hospital infrastructure, and technological advancements in IV equipment aimed at improving patient care and reducing infection risks

Intravenous (IV) Equipment Market Analysis

• Intravenous (IV) equipment plays a vital role in modern medical care by enabling the direct administration of fluids, medications, and nutrients into the bloodstream, ensuring rapid and controlled therapeutic effects
• The market is significantly driven by the rising global burden of chronic illnesses such as cancer, diabetes, and cardiovascular diseases, which often require long-term IV therapy for treatment and management
• North America is expected to dominate the IV equipment market with largest market share of 34.9%, due to its well-established healthcare infrastructure, high healthcare spending, and widespread adoption of advanced infusion technologies
• Asia-Pacific is expected to be the fastest growing region in the intravenous (IV) equipment market during the forecast period due growing investments in healthcare infrastructure, increasing hospital admissions, and rising awareness of infection control
• Peripheral catheters segment is expected to dominate the market with largest market share of 41.2% due to their applications and adaptability in various clinical practices. The peripheral catheters help deliver fluids, drugs, and blood products to the body with minimal complication risks, making them demanding in hospitals, outpatient facilities, and emergency care

Report Scope and Intravenous (IV) Equipment Market Segmentation

Intravenous (IV) Equipment Market Trends

“Technological Advancements in IV Equipment and Smart Infusion Systems”

• A significant trend in the intravenous (IV) equipment market is the increasing integration of advanced technologies such as smart IV pumps, automated infusion systems, and wireless connectivity
• These innovations are improving the accuracy and safety of IV therapy by providing real-time monitoring, reducing human error, and enhancing infusion control during patient treatment 
  • For instance, smart IV pumps equipped with dose error reduction systems (DERS) offer enhanced safety by alerting healthcare providers to potential issues like incorrect dosing, preventing medication errors and improving patient care outcomes 
• These advancements are transforming the IV therapy landscape, driving the adoption of more efficient and safer IV equipment, and are expected to boost the demand for smart infusion devices across various healthcare settings

Intravenous (IV) Equipment Market Dynamics

Driver

“Rising Demand Due to Increasing Prevalence of Chronic Diseases”

• The growing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is significantly driving the demand for intravenous (IV) equipment
• As these conditions require ongoing treatments such as chemotherapy, hydration, and pain management, the demand for IV systems is expected to rise to ensure proper medication administration and patient care
• The aging population is also contributing to the increasing incidence of these chronic diseases, further fueling the demand for reliable and efficient IV equipment

For instance,

• According to the World Health Organization (WHO), the global prevalence of diabetes is expected to rise significantly by 2045, leading to a higher need for regular IV treatments and supportive care in diabetic patients 
• As a result of the rising prevalence of chronic diseases, there is a marked increase in the demand for intravenous (IV) equipment to provide effective treatment and enhance patient outcomes

Opportunity

“Integration of Smart Technology and Remote Monitoring in IV Equipment”

• The integration of smart technology in intravenous (IV) equipment presents a significant opportunity, enabling remote monitoring and real-time data collection to improve patient care
• Smart IV pumps and infusion systems can automatically adjust medication delivery rates based on patient needs, enhancing safety and reducing the risk of human error
• Remote monitoring capabilities allow healthcare providers to track infusion data and patient status from a distance, enabling better management of critical care patients and improving overall treatment outcomes

For instance,

• In March 2024, according to an article published in the Journal of Infusion Nursing, smart infusion pumps that incorporate wireless connectivity and automated alerts can significantly reduce medication errors and improve patient safety, especially in intensive care units (ICUs) 
• The integration of these advanced technologies into IV equipment is expected to drive significant growth in the market by improving the efficiency and safety of treatments and enhancing patient outcomes

Restraint/Challenge

“High Costs of IV Equipment Limiting Accessibility in Healthcare Facilities”

• The high cost of advanced intravenous (IV) equipment is a significant barrier, particularly for healthcare facilities in developing regions or those with limited budgets
• High-end IV pumps and infusion systems can often cost thousands of dollars, which poses a challenge for smaller hospitals and clinics, limiting their ability to upgrade or invest in modern equipment
• This financial burden can prevent healthcare facilities from providing the best possible care, especially in critical care settings where high-quality equipment is crucial for patient safety

For instance,

• In February 2024, according to a report published by the International Federation of Medical and Biological Engineering (IFMBE), the high cost of sophisticated IV equipment remains a critical challenge in lower-income countries, limiting their access to life-saving technologies in emergency and intensive care units 
• As a result, this cost barrier can lead to inequalities in the quality of healthcare, impacting patient outcomes and hindering the broader adoption of advanced IV systems

Intravenous (IV) Equipment Market Scope

The market is segmented on the basis of product, and end user.

In 2025, the peripheral catheters is projected to dominate the market with a largest share in product segment

The peripheral catheters segment is expected to dominate the intravenous (IV) equipment market with the largest share of 41.2% due to their applications and adaptability in various clinical practices. The peripheral catheters help deliver fluids, drugs, and blood products to the body with minimal complication risks, making them demanding in hospitals, outpatient facilities, and emergency care

The hospitals and clinics is expected to account for the largest share during the forecast period in end user segment

In 2025, the hospitals and clinics segment is expected to dominate the market with the largest market share due to various factors, such as availability and accessibility of specialized departments and units within hospitals, such as ICUs, emergency departments, surgical suites, and general wards, where intravenous therapy is extensively utilized

Intravenous (IV) Equipment Market Regional Analysis

“North America Holds the Largest Share in the Intravenous (IV) Equipment Market”

• North America dominates the global intravenous (IV) equipment market with largest market share of 34.9%, driven by advanced healthcare infrastructure, widespread adoption of cutting-edge medical technologies, and the strong presence of key market players
• The U.S. holds a dominant market share of over 35%, due to the increased demand for high-precision IV therapies, rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions, and continuous advancements in IV technologies
• The availability of well-established reimbursement policies, coupled with growing investments in research and development by leading medical device companies, further strengthens the market
• The increasing number of hospital admissions and surgeries requiring IV support, along with a high rate of adoption of home healthcare services, is fueling market expansion across the region

“Asia-Pacific is Projected to Register the Highest CAGR in the Intravenous (IV) Equipment Market”

• The Asia-Pacific region is expected to experience the highest growth rate in the intravenous (IV) equipment market, driven by rapid expansion in healthcare infrastructure, rising awareness about intravenous therapies, and an increase in healthcare spending
• Countries like China, India, and Japan are emerging as key markets, fueled by a growing aging population, which is more susceptible to diseases requiring IV treatments, such as cancer, cardiovascular diseases, and diabetes
• Japan, with its advanced healthcare technology and increasing number of healthcare facilities, remains a crucial market for IV equipment. The country continues to lead in the adoption of innovative medical technologies for patient care
• China and India, with their large populations and rising incidence of chronic diseases, are witnessing increased government and private sector investments in healthcare infrastructure, including IV therapy-related equipment. The growing presence of global medical device manufacturers and improving access to advanced healthcare further contribute to the region’s market growth

Intravenous (IV) Equipment Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• B. Braun Melsungen AG (Germany)
• 3M (U.S.)
• Terumo Corporation (Japan)
• Abbott (U.S.)
• Teleflex Incorporated (U.S.)
• BD (U.S.)
• Henry Schein, Inc. (U.S.)
• Smiths Medical (U.S.)
• Baxter. (U.S.)
• Ascor S.A. (Switzerland)
• Moog Inc. (U.S.)
• AngioDynamics. (U.S.)
• ICU Medical, Inc. (U.S.)
• Fresenius SE & Co. KGaA (Germany)
• Animas LLC (U.S.)
• arcomed ag (Switzerland)
• International WIN, LTD. (U.S.)
• The Metrix Company (U.S.)

Latest Developments in Global Intravenous (IV) Equipment Market

• In August 2022, Baxter International Inc. obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Novum IQ Syringe Infusion Pump (SYR), featuring the advanced Dose IQ Safety Software. This development aligns with the growing demand for precision and safety in intravenous (IV) therapies, reflecting the broader trends in the global IV equipment market
• In April 2024, BD introduced "UltraTouch," a revolutionary device designed to enhance the blood collection process. This innovative solution minimizes patient discomfort and pain by ensuring a successful single-prick blood draw, which is particularly beneficial in addressing needle phobia, especially among first-time patients. This advancement reflects a growing trend toward patient-centric innovations in medical devices. By improving the blood collection experience, BD’s UltraTouch aligns with the demand for safer, more efficient IV procedures, contributing to the broader market’s focus on enhancing patient care and reducing procedural stress
• In November 2023, Medtronic announced the FDA approval of its "Symplicity Spyral" renal denervation (RDN) system, a minimally invasive device designed to treat hypertension. Also known as "Symplicity," this innovative system targets the renal nerves, which play a crucial role in regulating blood pressure. This development highlights the growing trend of minimally invasive technologies designed to improve patient outcomes
• In August 2022, Lineus Medical's SafeBreak Vascular received a Japanese utility patent, while its bifurcated venous access device (BVAD), a dual-lumen peripheral IV catheter, was granted a United States utility patent. This milestone highlights the innovation and expansion of specialized vascular access technologies. The SafeBreak Vascular and BVAD devices offer enhanced safety and efficiency in IV therapy, reinforcing the market’s growing focus on reducing complications such as accidental dislodgement and infusion-related risks
• In July 2022, B. Braun Medical Inc. introduced its new Introcan Safety 2 IV Catheter featuring one-time blood control functionality. This launch represents a key innovation in the global intravenous (IV) equipment market, addressing the increasing demand for safer and more efficient vascular access devices. The Introcan Safety 2 IV Catheter incorporates advanced safety features designed to minimize the risk of needlestick injuries and improve blood control during catheter insertion 

SKU-9533